5-(Difluoromethoxy)-2-mercapto-1H-benzimidazoleCAS: 97963-62-7
Catalog Number | XD93618 |
Product Name | 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole |
CAS | 97963-62-7 |
Molecular Formula | C8H6F2N2OS |
Molecular Weight | 216.21 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole is a chemical compound that holds significant potential in various medicinal applications. This compound belongs to the class of benzimidazole derivatives, which are known for their pharmacological activities.One of the notable uses of 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole is its role as an anti-cancer agent. Benzimidazole derivatives have demonstrated cytotoxic effects against various cancer cell lines by inhibiting cell growth and inducing apoptosis. The specific molecular modifications in 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole enhance its anticancer activity, potentially opening doors for novel treatment options in oncology.Another potential application of this compound lies in its antimicrobial properties. Benzimidazole derivatives have shown effective antimicrobial activity against a wide range of microorganisms, including bacteria, fungi, and parasites. This specific compound's unique structural features contribute to its antimicrobial potential, making it a promising candidate for combating drug-resistant pathogens and infectious diseases.Furthermore, 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole has exhibited anti-inflammatory activity. Inflammation plays a crucial role in the pathogenesis of various diseases, including chronic conditions like rheumatoid arthritis and inflammatory bowel disease. The compound's anti-inflammatory properties make it a potential candidate for developing new therapeutics for such conditions.Additionally, benzimidazole derivatives have also been explored for their potential role in central nervous system disorders. Certain compounds in this class have shown neuroprotective effects and the ability to enhance memory and cognitive functions. It is possible that 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole could exhibit similar effects, making it a potential candidate for the development of treatments for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.However, it is important to note that 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole is still under investigation, and further research is needed to determine its full therapeutic potential, safety, and optimal applications. It is crucial for any potential pharmaceutical compound to undergo rigorous testing, including preclinical and clinical trials, to establish its efficacy and safety profile.It is always important to consult with healthcare professionals and experts in the field for accurate information and guidance regarding the specific uses, dosing, and potential side effects of any pharmaceutical compound.